ADMET Predictions
State-of-the-art prediction of absorption, distribution, metabolism, excretion, and toxicity using deep learning.
- Validated AI algorithms
- Lipinski & Veber compliance
- Instant comprehensive reports
Accelerate drug discovery with cutting-edge AI. From ADMET analysis to virtual screening and automated molecule generation, MolForge transforms your R&D pipeline.
MolForge combines AI with advanced scientific methods to deliver comprehensive molecular analysis and drug design capabilities.
State-of-the-art prediction of absorption, distribution, metabolism, excretion, and toxicity using deep learning.
Screen massive compound libraries with AutoDock Vina and advanced scoring functions.
Design novel molecules using RL, VAE, and GANs optimized for drug-likeness.
GROMACS integration for protein-ligand stability analysis and binding validation.
Comprehensive clustering, similarity analysis, and interactive 3D visualization.
Direct access to millions of compounds from the PubChem database.
From target discovery to clinical trials, revolutionize every stage of pharmaceutical development with measurable results.
Leverage deep learning trained on 50M+ papers to identify novel drug targets with 90% validation rate.
Screen billions of compounds in hours with GPU-accelerated docking achieving 1M compounds/hour.
Generate 10K+ novel drug candidates daily using RL and GANs, with 85% achieving drug-likeness.
Achieve 92% prediction accuracy with models trained on 2M+ data points, reducing failures by 60%.
Transform hits into clinical candidates 5X faster with multi-objective Bayesian optimization.
Run 100+ GROMACS simulations daily with automated analysis achieving 88% correlation.
Unify 500M+ data points from PubChem, ChEMBL, and proprietary sources with NLP-powered mining.
Streamline team collaboration with integrated project management and 99.9% uptime.
Join leading pharmaceutical companies and research institutions using MolForge to revolutionize drug discovery.